FDA Inspection 1023396 — Continental Services Group, Inc.
The FDA completed an inspection of Continental Services Group, Inc. on August 22, 2017 in Miami, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 22, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Miami, FL (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 12203 | 21 CFR 606.170(a) | Adverse Reaction- Reports of Investigations |
| 337 | 21 CFR 640.65(b)(1)(iii) | Greater than six months since four month sample |
| 41 | 21 CFR 606.40(a)(1) | Provide space for examination |